A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response

被引:14
|
作者
Lin, Yi-Chun [1 ,2 ]
Cheng, Chien-Yu [1 ,3 ]
Chen, Cheng-Pin [1 ,4 ]
Cheng, Shu-Hsing [1 ,5 ]
Chang, Sui-Yuan [6 ,7 ]
Hsueh, Po-Ren [7 ,8 ]
机构
[1] Taoyuan Gen Hosp, Dept Internal Med, Div Infect Dis, Minist Hlth & Welf, Taoyuan, Taiwan
[2] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Publ Hlth, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[5] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan
[6] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan
[7] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Lab Med, Coll Med, Taipei, Taiwan
[8] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan
关键词
COVID-19; SARS-CoV-2; Asymptomatic infection; Colonization; Contamination;
D O I
10.1016/j.ijid.2020.05.070
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We report the case of a patient who had travelled to Japan and who presented mild respiratory symptoms during the COVID-19 outbreak period. There was transient existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in his oropharynx. The RNA was absent in the six respiratory specimens that were subsequently tested. An anti-SARS-CoV-2 antibody response was absent in the acute and convalescent sera. The reported case indicates that transient colonization of SARS-CoV-2 in the upper respiratory tract is possible without inciting any antibody response against the virus. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:464 / 466
页数:3
相关论文
共 50 条
  • [21] Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
    Soumya Jaganathan
    Francis Stieber
    Sonia N. Rao
    Vladyslav Nikolayevskyy
    Davide Manissero
    Nadia Allen
    Jeff Boyle
    Jenny Howard
    Infectious Diseases and Therapy, 2021, 10 : 2765 - 2776
  • [22] Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
    Jaganathan, Soumya
    Stieber, Francis
    Rao, Sonia N.
    Nikolayevskyy, Vladyslav
    Manissero, Davide
    Allen, Nadia
    Boyle, Jeff
    Howard, Jenny
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2765 - 2776
  • [23] SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs
    Bharadwaj, Shiv
    Azhar, Esam Ibraheem
    Kamal, Mohammad Amjad
    Bajrai, Leena Hussein
    Dubey, Amit
    Jha, Kanupriya
    Yadava, Umesh
    Kang, Sang Gu
    Dwivedi, Vivek Dhar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (06) : 2769 - 2784
  • [24] Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
    Elena Riester
    Mario Majchrzak
    Annelies Mühlbacher
    Caroline Tinguely
    Peter Findeisen
    Johannes Kolja Hegel
    Michael Laimighofer
    Christopher M. Rank
    Kathrin Schönfeld
    Florina Langen
    Tina Laengin
    Christoph Niederhauser
    Infectious Diseases and Therapy, 2021, 10 : 2381 - 2397
  • [25] Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection?
    Lippi, Giuseppe
    Henry, Brandon M.
    Pighi, Laura
    De Nitto, Simone
    Salvagno, Gian Luca
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (02): : 175 - 179
  • [26] Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19
    Jacobs, Jana L.
    Naqvi, Asma
    Shah, Faraaz A.
    Boltz, Valerie F.
    Kearney, Mary F.
    McVerry, Bryan J.
    Ray, Prabir
    Schaefer, Caitlin
    Fitzpatrick, Meghan
    Methe, Barbara
    Lee, Janet S.
    Morris, Alison
    Mellors, John W.
    Kitsios, Georgios D.
    Bain, William
    JOURNAL OF INFECTIOUS DISEASES, 2022, : 2089 - 2094
  • [27] The Impact of SARS-CoV-2 on Work Absence
    Etli, Dominic
    Wiewior, Antonina
    Malone, Alex
    Locke, Ken
    Bullock, Nicholas
    Howard, Raina
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2025, 67 (03) : e139 - e151
  • [28] Existence of SARS-Cov-2 in the Peritoneal Fluid
    Ilgen, Orkun
    Ozgozen, Mehmet Eyuphan
    Appak, Ozgur
    Ertan, Begum
    Timur, Hikmet Tunc
    Dogan, Omer Erbil
    Posaci, Cemal
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (05): : 261 - 265
  • [29] Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGTI Deficiency
    Jalil, Maaz
    Rowane, Marija
    Rajan, Jayanth
    Hostoffer, Robert, Jr.
    ALLERGY & RHINOLOGY, 2021, 12
  • [30] Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
    Cao, Ruiyuan
    Hu, Hengrui
    Li, Yufeng
    Wang, Xi
    Xu, Mingyue
    Liu, Jia
    Zhang, Huanyu
    Yan, Yunzheng
    Zhao, Lei
    Li, Wei
    Zhang, Tianhong
    Xiao, Dian
    Guo, Xiaojia
    Li, Yuexiang
    Yang, Jingjing
    Hu, Zhihong
    Wang, Manli
    Zhong, Wu
    ACS INFECTIOUS DISEASES, 2020, 6 (09): : 2524 - 2531